Current estimates of national, state-level, and county-level prevalence of US adults reporting a lifetime diagnosis of depression

More than 200 med­i­cines at risk of short­ages in the EU have been list­ed as crit­i­cal by the Eu­ro­pean Com­mis­sion, the Heads of Med­i­cines Agen­cies

Cost and re­search cuts across biotech and phar­ma are af­fect­ing some of the con­tract­ing com­pa­nies that re­ly on the in­dus­try. The lat­est vic­tim is Icon